Uterine cancer is one of the few cancers with increasing mortality; since the mid-2000s the death rate has risen by 1.7% per year. Black women are more likely to die from it. There are more than ...

Uterine cancer is one of the most common forms of cancer, and there are two distinct types. The more common type of uterine cancer is endometrial cancer, while the less common is uterine sarcoma.

A study looking at AZD8205 for cancer that has spread or come back after treatment (Sub-study 1) This study is looking at a drug called AZD8205 for solid cancers that have spread to another part of ...

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.

Surgery is the cornerstone of treatment for uterine (endometrial) cancer at Memorial Sloan Kettering. For many women, it’s used for removing the cancer as well as diagnosis and staging information.

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Merck & Co's KEYNOTE-158 trial of Keytruda has underpinned another FDA approval, this time for the PD-1 inhibitor ... cervical cancer. Endometrial carcinoma is the most common type of cancer ...

It is an immune checkpoint inhibitor, which is a type of ... on average 13.1 months without their cancer progressing. That’s compared to 8.7 months for those who received only chemotherapy. PMMR ...